Hiperparatiroidismo secundario a insuficiencia renal crónica y osteodistrofia renal
Contenido principal del artículo
Resumen
Debido a que la esperanza de vida de los pacientes con insuficiencia renal crónica era muy corta antes del advenimiento de la hemodiálisis, la secuela de la destrucción progresiva de las nefronas no se había estudiado con seriedad. Ya que estos pacientes en la actualidad se mantienen con diálisis O transplante renal, es importante identificar y resolver en forma temprana los problemas de manejo crónico, entre éstos la osteodistrofia renal, con el fin de disminuir las complicaciones proporcionando de esta manera una mejor calidad de vida para estos pacientes, por lo cual hemos hecho una revisión de la literatura sobre el tema en los últimos 4 años.
Detalles del artículo
Sección
Cómo citar
Referencias
Brookhyser J, Pahre SN. Dietary and pharmacotherapeutic considerations in the managent of renal osteodystrophy. Advances in renal replacement therapy 1995; 2: 5-13.
Neonakis E et al. Results of surgical treatment of renal hyperparathyroidism. Archives of surgery 1995: 130:643
Goodman WG et al. Development of adynamic bone in patient with secondary hyperparathyroidism after intermitent calcitriol therapy. Kidney lnternational 1994: 46: 1160-6.
Bianchi ML et al. Calcitrol and calcium carbonate therapy in early chronic renal failure. Nephrology, Dialysis. Transplantation 1994: 9:1595-9.
Rubini G et al. Renal Osteodystrophy with hyperparathyroidism: the diagnostic value of intact parathormone alkaline phosphathase osteocalcin and procollagene. Joumal oí Nuclear biology &. Medicine 1994:38: 489-94.
Hutchison AJ et al. Correlanons of hone hystiology with parathyroid hormone, vitamin D, and radiology in end-stage renal disease. Kidney lnternational 1993: 44: 1071-7.
Kim HC et al. Long term results of subtotal parathyroidectomy in patients with end-stage renal disease. American Surgeon 1994: 60: 641-9.
Goodman WG. Coburn JM. The use of 1.25 (OH)2D3 in early renal failure Annual Review of Medicine 1992: 43: 227-37.
Peacock E. Calcitriol injection tor the management of renal osteodystrophy. Annal Journal 1992; 19: 575-7.
Fukagawa M. Kurokawa K. Renal osteodystrophy and vitamin D derivatives: cellular mechanisms of hyperparathyroidism in uremia. Journal of Nutritional Science & Vitaminology. Spec No.1992: 96-9.
Finch JL. Differential effects of 1.25 (OH)2D1 and 22 oxacalcitriol on phosphate and calcium metabolism. Kidney International 1993: 43:561-6.
McCarthy JT. The imponance of bone biopsy in managing renal osteodystrophy. Advances in Renal Replacement Theraphy 1995: 2: 148-59.
Kmul JA. The role of metabolic acidosis in pathogenesis of renal osteodystrophy. Advances in Renal Replacement Therapy 1995: 2: 40-51.
Morio K. Koide K. Secondary hyperparathyroidism and tertiary hyperparathyroidism chronic renal failure. uremia. Nippon Rinsho-Japanese Journal of Clinical Medicine 1995; 53:954-64.
Goodman WG et al. Bone metabolic activity measured with positron emission tomography and (18F) fluoriode ion renal osteodistrophy: correlation with bone; histomorphometry. Journal of Clinical Endocrinology and Metabolism 1993:77: 949-15.
Greenan DM et al. Renal disease and rheumatic manifestations. Current opinion in Rheumatology 1994: 6: 82-4.
Jorgetti V et al. Aluminium related Osteodystrophy and desferrioxamine treatment role of phosphorus. Nephrology, Dialysis. Transplantation 1994: 9: 666-74.
Kurz P et al. Evidence for abnormal calcium homeostasis in patients with adynamie bone disease. Kidney lnternational 1994; 46: 855-61.
Malluche HH. The possible use of bisphosphonates in the treatment of renal osteodystrophy. Clinical Nephrology 1992: 38(Suppl I): 887-91.
Kalef-Ezra JA et al. Bone mineral status after renal transplantation. Assesment by noninvasive techniques. Investigative Radiology 1994: 29: 127-33.
Hutchison AJ. Gokal R. Vitamin D therapy in continuous ambulatory peritoneal dialysis: what is its role? Advances in Peritoneal Dialysis 1993: 9: 253-6.
Sherrard DJ et al. The spectrum of bone disense in end-stage renal failture -mi an evoluting disorder. Kidney lnternational 1993; 43: 436-42.
Murphey MD et al. Musculoeskeletal manifestations of chronic renal insuficiency. Radiographics 1993; 13: 357-79.
Bedani PL et al. Clinical and radiological features of bone disease in long-terrn ( 15 or more years) hemodialysis patients. International Journal of Artificial Organs 1993: 16: 704-10.
Bushinsky DA. The contribution of acidosis to renal osteodistrophy. Kidney lnternational 1995: 47: 1816-32.
Brunier GM. Calcium/phosphate imbalances. aluminium toxicity, and renal osteodystrophy. Annal Journal 1994; 21: 171-7. 179-9.
Israel O et al. Bone loss in patients with chronic renal disease: prediction with quantitative bone signigraphy with SPECT. Radiology 1995;196: 643-6.
Herez G et al. Aplastic osteodystrophy without aluminium: the role of "suppressed" parathyroid function. Kidney lnternational 1993; 44:860-6.
Pey Y et al. Risk factors for renal osteodystrophy: a multivariante analysis. Journal of Bone & Mineral Research 1995: 10: 149-56.
Malluche HH et al. Risk of dynamic bone disease in dialyzed patients. Kidney lnternational 1992; Suppl 38: 862-7.
DeVita MV. Assessment of renal osteodystrophy in hermodialysis patients, Medicine 1992: 71: 284-90.
Taylor et al. Parathyroidectomy in uremic hyperparathyroidism: a clinical study. Scottish Medical Journal 1992: 37: 18-21.